Multiple approved treatments , including copyright and Semaglutide, belong to the incretin mimetic class . Essentially , these therapies are designed to mimicking endogenous chemicals that regulate blood https://geraldmvko092767.post-blogs.com/61961897/these-medications-and-the-class-getting-to-know-the-treatments